These guidelines have been drafted by the Urological Society of India benign prostatic hyperplasia/obstruction ((BPH//BPO) guidelines panel and address management of BPH/BPO. The guidelines are intended for urologists and the recommendations are updated till January 2021. These will remain valid until the next update or for a maximum period of 5 years. The guidelines should not be regarded as a rigid clinical pathway for every patient and are not intended to replace clinical judgment. These guidelines should not be viewed as legal standards of care. This executive summary includes some salient aspects of the guidelines and the guideline statements.